14/11/2017 18:29:04

SmarTech and 3DPrint.com Announces “The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit”

CHARLOTTESVILLE, Va., Nov. 14, 2017 (GLOBE NEWSWIRE) -- On January 22 and 23, 2018 in Washington DC, SmarTech and 3DPrint.com will be holding a conference on “The Future of 3D Printing in Medicine and Dentistry” More details about this “Business & Investment Summit” can be found at https://additivemanufacturingstrategies.com.

What The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit
WhenJanuary 22 – January 23
Where The Army and Navy Club

901 17th St NW, Washington, DC 20006

Registration

https://additivemanufacturingstrategies.com/register/?options=registration

 

Save 25%, register by November 15

 

For more details (917) 403-6300

ams@3dprint.com

  • This is the first business-oriented conference focused on additive manufacturing in the medical and dental sectors.  Attendees will have the opportunity to hear senior executives from 3D Systems, Carbon, EOS, GE Additive, HP, Materialise, Oxford Performance Materials, Stratasys, along with innovative start-ups discuss how they plan to capture revenues from this multi-billion dollar opportunity. In addition, there will be presentations from leading practitioners on where they are seeing the advantages for additive manufacturing emerge in hospitals, labs and doctor’s offices.

     

  • SmarTech's analysts will also be at the Summit; giving our view of where medical/dental 3DP is headed commercially as well as sharing our latest medical and dental 3DP forecasts. SmarTech is the leading industry analyst firm specializing the additive manufacturing space and has published numerous market studies on medical and dental 3DP as well as carrying out demanding consulting work in these areas. At the Summit, our analysts will provide a realistic view of what 3D-printing applications will become a standard fabrication process and which will stay in the medical and dental labs for years to come. Our analysts will also provide insight into the value chains that will emerge in this area.

     

  • Summit Attendees will also gain insight into where the investment money will be coming from for “additive medicine and dentistry,” and what kind of financial deals will be struck in this area in the coming years. It will also provide clarity on how intellectual property and regulatory factors will impact investment considerations in this area

“The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit” is designed to guide managers, entrepreneurs and investors to the most profitable opportunities in 3D-printed prosthetics, implants, medical models and personal medicine, as well as bioprinting and 3D-printed dental devices – sectors that will generate more than $5 billion in revenues by 2021, according to SmarTech’s latest analysis.

In addition to being source of information on the latest developments in medical and dental 3D printing, this must-attend conference will provide the kind of environment where alliances will be formed and deals will be done between important players in the 3DP space.  It is intended for marketing, business development and product management as well as investors and healthcare professionals of all kinds.

For further details:

(917) 403-6300

ams@3dprint.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
17 Nov
ALMB
Når man dagligt læser indlæg fra Alpehuen, Mackkeith, Malurt, EMEA (MENA), Powertrade som via en flo..
30
17 Nov
PNDORA
Om nogen, har jeg ikke meget tilovers for GW, men jeg har tilladt mig at anmelde dit indlæg. Nu må i..
29
20 Nov
I:SP500
God aften   Gå lige ind under Conference Board i USA og læs, at de ledende indikatorer steg med hele..
25
16 Nov
NOVO-B
Og Goodwrench, Baronen og marc55
25
20 Nov
VWS
Roland, nu må du simpelthen stoppe. Det her er simpelthen for ynkeligt, hvordan kan du være så selvi..
23
17 Nov
OMXC20
  Her kommer en kort gennemgang og forklaring på, hvorfor aktietilbagekøb både kan være rigtig godt ..
23
21 Nov
PNDORA
Hej Roland.   Dem du prøver at råde om aktiehandel, fortjener at vide hvilken tåbe, der prøver at rå..
20
18 Nov
I:NDX
Der er efterhånden alt for få på EI, der bruger hovedparten af deres tid på at tjene penge på aktier..
18
19 Nov
PNDORA
Hvad skal vi med millionærklubben når vi har roland333 
17
16 Nov
VWS
Lavede en kæmpe fodfejl med Vestas. Købte i den private frie pot 1200 stk med gak 402,8 fordi jeg..
15

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

22/11/2017 10:18:00
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Majedie Asset Management Ltd : Form 8.3 - TESCO PLC

21/11/2017 15:35:27
FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code")   1.         KEY INFORMATION   (a) Full name of discloser: ..

Alliance Trust PLC : Net Asset Value(s)

21/11/2017 13:37:22
ALLIANCE TRUST PLC                                    At the close of business on Monday 20 November 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 778.0p -       including income, 787.7p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding inc..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Newtek Technology Solutions Joins the VMware Cloud Provider™ Program
2
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
3
Sprouts Farmers Market to Present at the Barclays 2017 Eat, Sleep, Play – It’s Not All Discretionary Conference
4
Franklin Electric Launches Four New Key Dealer Tutorial Videos To Help Contractors Maximize Program Value
5
Portola Pharmaceuticals Provides Update on Bevyxxa® (betrixaban) Commercial Launch

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 November 2017 14:43:50
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB3 - 2017-11-22 15:43:50 - 2017-11-22 14:43:50 - 1000 - Website: OKAY